NDLI: Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

Content Provider	PubMed Central
Author	Ernest, Milián Kamen, Amine A.
Copyright Year	2015
Abstract	Annually, influenza virus infects millions of people worldwide. Vaccination programs against seasonal influenza infections require the production of hundreds of million doses within a very short period of time. The influenza vaccine is currently produced using a technology developed in the 1940s that relies on replicating the virus in embryonated hens' eggs. The monovalent viral preparation is inactivated and purified before being formulated in trivalent or tetravalent influenza vaccines. The production process has depended on a continuous supply of eggs. In the case of pandemic outbreaks, this mode of production might be problematic because of a possible drastic reduction in the egg supply and the low flexibility of the manufacturing process resulting in a lack of supply of the required vaccine doses in a timely fashion. Novel production systems using mammalian or insect cell cultures have emerged to overcome the limitations of the egg-based production system. These industrially well-established production systems have been primarily selected for a faster and more flexible response to pandemic threats. Here, we review the most important cell culture manufacturing processes that have been developed in recent years for mass production of influenza vaccines.
Related Links	http://dx.doi.org/10.1155/2015/504831
Starting Page	504831
File Format	PDF
ISSN	23146133
e-ISSN	23146141
Journal	BioMed Research International
Volume Number	2015
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2015-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Microbiology Medicine Biochemistry, Genetics and Molecular Biology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Current and Emerging Biomarkers of Cell Death in Human Disease

Development of a mammalian cell culture process for rapid Clinical-Scale production of novel Influenza Nanoparticle vaccines

Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture

New Technologies for Influenza Vaccines

Materials and Manufacturing Technologies Available for Production of a Pediatric Bioabsorbable Stent

Emerging Roles for the Influenza A Virus Nuclear Export Protein (NEP)

Environmental Biotechnology: Current Advances, New Knowledge Gaps, and Emerging Issues

Challenges and Strategies of Laboratory Diagnosis for Newly Emerging Influenza Viruses in Taiwan: A Decade after SARS

Emerging technologies for the genomic analysis of cancer

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

Similar Documents

Current and Emerging Biomarkers of Cell Death in Human Disease

Development of a mammalian cell culture process for rapid Clinical-Scale production of novel Influenza Nanoparticle vaccines

Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture

New Technologies for Influenza Vaccines

Materials and Manufacturing Technologies Available for Production of a Pediatric Bioabsorbable Stent

Emerging Roles for the Influenza A Virus Nuclear Export Protein (NEP)

Environmental Biotechnology: Current Advances, New Knowledge Gaps, and Emerging Issues

Challenges and Strategies of Laboratory Diagnosis for Newly Emerging Influenza Viruses in Taiwan: A Decade after SARS

Emerging technologies for the genomic analysis of cancer

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines